HIV and the 7-transmembrane domain receptors

Pathobiology

Volumn 64, Issue 4, 1996, Pages 171-179

  Broder, Christopher C ^a   Dimitrov, Dimiter S ^b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Chemokines; Fusion; HIV 1; Receptors

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MEMBRANE RECEPTOR; RANTES; VIRUS ENVELOPE PROTEIN; VIRUS RECEPTOR;

COMPLEX FORMATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; VIRUS CELL INTERACTION; VIRUS ENVELOPE;

EID: 0030451267     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000164032     Document Type: Article

References (108)

1. Feng Y, Broder CC, Kennedy PH, Berger HA: HIV-I entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996:272:872-877.
2. Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA: The CD4 (T4) antigen is an essential component of the receptor of the AIDS retrovirus. Nature 1984:312:763-767.
3. Klatzman D, Champagne H, Chamaret S, Gruest J, Guetard D, Hercend T, Gluekman JC, Montagnier L: T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984;312:767-768.
4. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R: The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986:47:333-385.
5. Evans LA, Mchugh TM, Stites DP, Levy JA: Differential ability of HIV isolates to productively infect human cells. J Immunol 1987:138: 3415-3418.
6. Clapham P, Weber JN, Whitby D, McKintosh K, Dalgleish AG, Maddon PJ, Deen KC. Sweet RW, Weiss RA: Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature’1989:337:368-370.
7. Ashorn PA, Berger HA, Moss B: Human immunodeficiency virus envelope glycoprotein/ CD4-mediatcd fusion of nonprimate cells with human cell. J Virol 1990:64:2149-2156.
8. Clapham PR, Blanc D, Weiss RA: Specific cell surface requirements for infection of CD4-pos-itivc cells by human immunodeficiency virus type I, type 2 and simian immunodeficiency virus. Virology 1991:181:703-715.
9. Chesebro B, Buller R, Portis J, Wehrly K: Failure of human immunodeficiency virus entry' and infection in CD4-posilive human brain and skin cells. J Virol 1990;64:215-221.
10. Aoki N, Shioda T, Satoh H, Shibuta H: Syneytium formation of human and non-human cells by recombinant vaccinia viruses carrying the HIV env gene and human CD4 gene. AIDS 1991:5:871-875.
11. Clapham PR, McKnight A, Weiss RA: Human immunodeficiency virus type 2 infection and fusion of CD4-ncgativc human cell lines: Induction and enhancement by soluble CD4. J Virol 1992:66:3531-3537.
12. Harrington RD, Geballe AP: Cofactor requirement for human immunodeficiency virus type I entry into a CD4-expressing human cell line. J Virol 1993:67:5939-5947.
13. Fantini J, Yahi N, Delczay O, Gonzalez-Scarano F: GalCer, CD26 and HIV infection of intestinal epithelial cells. AIDS 1994:8:1347-1348.
14. Weiner DB, Huebner K, Williams WV. Greene MI: Human genes other than CD4 facilitate HIV-I infection of murine cells. Pathobiology 1991;59:361-371.
15. Dragic T, Charneau P, Clavel F, Alizon M: Complementation of murine cells for human immunodeficiency virus envelope/CD4-me-diated fusion in human/murine heterokaryons. J Virol 1992:66:4794-4802.
16. Broder CC, Dimitrov DS, Blumenthal R, Berger EA: The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s). Virology 1993:193: 483-491.
17. Golding H, Manischewitz J, Vujcic L, Blumenthal R, Dimitrov DS: The phorbol ester phor-bol myristatc acetate inhibits human immunodeficiency virus type I envelope-mediated fusion by modulating an accessory components) in CD4-expressing cells. J Virol 1994: 68:1962-1969.
18. Golding H, Dimitrov DS, Manischewitz J, Broder CC, Robinson J, Fabian S, Littman DR. Lapham CK: Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gpl20 and suggests a role for accessory molecules. J Virol 1995:69: 6140-6148.
19. Dragie T, Picard L, Alizon M: Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins. J Virol 1995;69: 1013-1018.
20. Puri A, Morris SJ, Jones P, Ryan M, Blumenthal R: Heat-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing HIV-I envelope glycoproteins. Virology 1996;219:262-267.
21. Moore J, Jameson B, Weiss R, Sattentau Q: The HIV-cell fusion reaction: in Bentz J (ed): Viral Fusion Mechanisms. Boca Raton CRC Press. 1993, pp 233-289.
22. Alizon M, Dragic T: CD26 antigen and HIV-fusion? Science 1994:264:1161-1162.
23. Broder CC, Nussbaum O, Gutheil WG. Bachovchin WW. Berger HA: CD26 antigen and HIV fusion? Science 1994:264:1156-1159.
24. Camerini D, Planelles V, Chen ISY: CD26 antigen and HIV fusion? Science 1994:264: 1160-1161.
25. Lazaro I, Naniche D, Signoret N, Bernhard A-M, Marguet D, Klalzmann D, Dragic T, Alizon M, Sattentau Q: Factors involved in entry of the human immunodeficiency virus type I into permissive cells: Lack of evidence of a role for CD26. J Virol 1994:68:6535-6546.
26. Patience C, McKnight A, Clapham PR, Boyd MT, Weiss RA, Schulz T: CD26 antigen and HIV fusion? Science 1994:264:1159-1160.
27. Werner A, Mattem T, Ulmer AJ, Flad HD, Kurth R, Baier M: CD26 is not required for infection of the lymphoma cell lineC8166 with HIV-I. AIDS 1994:8:1348-1349.
28. West WHL, Stott EJ: Cell surface expression of CD26 does not correlate with susceptibility to immunodeficiency viruses. AIDS 1994;8: 1349-1350.
29. Nussbaum O, Broder CC, Berger HA: Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J Virol 1994: 68:5411-5422.
30. Berson JF, Long D, Doranz BJ, Rucker J, Jirik FR. Dorns RW: A seven transmembrane domain receptor involved in fusion and entry of T-cell tropic human immunodeficiency virus type-1 strains. J Virol 1996;70:6288-6295.
31. Federspiel B, Melhado IG, Duncan AMV, Delaney A, Schappert K, Clark-Lewis I, Jirik FR: Molecular cloning of the cDNA and chromosomal localization of the gene for a putative sevcn-transmembrane segment (7-TMS) receptor isolated from human spleen. Genomics 1993;16:707-712.
32. Herzog H, Hort YJ, Shine J, Selbie LA: Molecular cloning, characterization, and localization of the human homolog to the reported bovine NPY Y3 receptor: Lack of NPY binding and activation. DNA Cell Biol 1993:12:465-471.
33. Jazin EE. Yoo H, Blomqvist AG, Yec F, Weng G, Walker MW, Salon J, Larhammar D, Wah-lestedt C: A proposed bovine neuropeptide Y (NPY) receptor cDNA clone, or its human homologuc. confers neither NPY binding sites nor NPY responsiveness on transfected cells. Regul Pept 1993;47:247-258.
34. Nomura H, Nielsen BW. Matsushima K: Molecular cloning of cDNAs encoding a LD78 receplor and putative leukocyte chemotaclic peptide receptors. Int Immunol 1993:5:1239-1249.
35. Loetschcr M, Geiser T, O'Reilly T, Zwahlen R, Baggiolini M, Moser B: Cloning of a human sevcn-transmembrane domain receptor, LESTR that is highly expressed in leukocytes. J BiolChem 1994:269:232-237.
36. Bleui CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA: The lymphocyte chcmoattractant SDS-I is a ligand for LESTER/fusin and blocks HIV-l entry. Nature 1996;382:829-833.
37. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier J-L. Arenzana-Seisdedos F, Schwartz O, Heard J-M. Clark-Lewis I, Legier DF, Loetscher M, Baggiolini M, Moser B: The CXC chemokine SDF-1 is the ligand for LESTER/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996:382:833-835.
38. Murphy PR: The molecular biology of leukocyte chemoattractanl receptors. Annu Rev Immunol 1994;12:593-633.
39. + T cells. Science 1995:270:1811-1815.
40. Paxton WA, Martin SR, Tse D, O'Brien TR, Skumick J, VanDevanter NL, Padian N, Braun JF, Kotier DP, Wolinsky SM, Koup RA: Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Med 1996:2:412-417.
41. Combadiere C, Ahuja SK, Murphy PM: Cloning and functional expression of a human eosinophil CC chemokinc receptor (correction). J Biol Chem 1995;270:302-356.
42. Combadiere C, Ahuja SK. Murphy PM: Cloning and functional expression of a human eosinophil CC chemokine receptor. J Biol Chem 1995;270:16491-16494.
43. Samson M, Labbe O, Mollereau C, Vassart G, Parmenlier M: Molecular cloning and functional expression of a new human CC-chemo-kine receptor gene. Biochemistry 1996:35: 3362-3367.
44. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA: CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
45. Choc H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W. Gerard N, Gerard C, Sodroski J: The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-1148.
46. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Marzio PD. Marmon S, Sutton RE, Hill CM, Davis CB. Peipcr SC. Schall TJ. Littman DR, Landau NR: Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-666.
47. Doranz BJ. Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC. Parmentier M, Collman RG. Doms RW: A dual-tropic primary HIV-1 isolate that uses fusin and the β-chcmokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85:1149-1158.
48. + cells is mediated by the chemokine receptor CC-CKR5. Nature 1996; 381:667-673.
49. Schmidtmayerova H, Sherry B, Bukrinsky M: Chemokines and HIV replication. Nature 1996:382:767.
50. Baldwin JM: The probable arrangement of the helices in G protein-coupled receptors. EMBO J 1993; 12:1693-1703.
51. Strader CD, Fong TM, Tota MR, Underwood D, Dixon RA: Structure and function of G protein-coupled receptors. Annu Rev Biochcm 1994:63:101-132.
52. Holmes WE, Lee J, Kuang W-J. Rice GC, Wood WI: Structure and functional expression of a human interleukin-8 receptor. Science 1991:253:1278-1280.
53. Loetschcr M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B: Chemokine receptor specific for IP10 and Mig: Structure, function, and expression in activated T-lymphocytes. J Exp Med 1996:184: 963-969.
54. Neotc K, DiGregorio D, Mak JY. Horuk R, Schall TJ: Molecular cloning, functional expression, and signaling characteristics of a C-C chemokinc receptor. Cell 1993:72:415-425.
55. Charo IF, Meyers SJ. Herman A, Franci C, Connolly AJ, Coughlin SR: Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci USA 1994;91:2752-2756.
56. Yamagami S, Tokuda Y, Ishii K, Tanaka H, Endo N: cDNA cloning and functional expression of a human monocyte chemoattractant protein 1 receptor. Biochem Biophys Res Commun 1994;202:1156-1162.
57. Franci C, Wong LM, Damme JV, Proosl P, Charo IF: Monocyte chemoattractanl protein-3, but not monocyte chemoattractant protein-2, is a functional ligand of the human monocyte chemoattractant protein-1 receptor. J Immunol 1995;154:6511-6517.
58. Power CA, Meyer A, Nemeth K, Bacon KB, Hoogewerf AJ, Proudfoot AEI, Wells TNC: Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J Biol Chem 1995: 270:19495-19500.
59. Wimmer E: Introduction; in Wimmer E (ed): Cellular Receptors for Animal Viruses. New York, Cold Spring Harbor Laboratory Press, 1994, pp 1-13.
60. Capon DJ. Ward RHR: The CD4-gp120 interaction and AIDS pathogenesis. Annu Rev Immunol 1991:9:649-678.
61. McDougal JS, Klatzmann DR, Maddon PJ: CD4-gp120 interactions. Curr Opin Immunol 1991;3:552-558.
62. Blumcnthal R, Dimitrov DS: Membrane fusion: in Hoffman JF. Jamieson JC (eds): Handbook of Physiology. New York. Oxford University Press, 1996, vol 1, p 14.
63. Sattentau QJ, Moore JP: Conformational changes in the human immunodeficiency virus envelope glycoproteins by soluble CD4 binding. J Exp Med 1991:174:407-415.
64. + cells. J Virol 1992;66:4784-4793.
65. Hattori T, Koito A, Takatsuki K, Kido H, Katunuma N: Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection. FEBS Lett 1989:248: 48-52.
66. Clements GJ, Price-Jones MJ, Stephens PE, Sutton C, Schultz TF, Clapham PR, McKealing JA, McClure MO, Thomson S, Marsh M, Kay J, Weiss RA, Moore JP: The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic sites: A possible function in viral fusion? AIDS Res Hum Retroviruses 1991;7:3-16.
67. Kirsli P, Hart TK, Ellens H, Miller J Jr., Lambert DM, Leary J, Bugelski PJ: Morphometric analysis of recombinant soluble CD4-mediatcd release of the envelope glycoprotein gp!20 from HIV-1. AIDS Res Hum Retroviruses 1990;6:1209-1212.
68. Moore JP, McKeating JA, Weiss RA, Sattentau QJ: Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 1990:250: 1130-1142.
69. Berger EA, Lifson JD, Eiden LE: Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: Implications for the role of the complementarity-determining region 3-like region in membrane fusion. Proc Natl Acad Sci USA 1991:88:8082-8086.
70. Bugelski PJ, Ellens H, Hart TK, Kirsh RL: Soluble CD4 and dextran sulfate mediate release of gpl20 from HIV-1-implications for clinical trials. J Acquir Immune Defic Syndr 1991;4:923-924.
71. Hart TS, Kirsh R, Ellens H, Sweet RW, Lambert DM, Petteway SR, Leary J, Bugelski PJ: Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp 120. Proc Natl Acad Sci USA 1991:88:2189-2193.
72. Moore JP, McKeating JA, Huang Y, Ashkenazi A, Ho DD: Virions of primary human immunodeficiency virus type I isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gpl20 retention from sCD4-scnsitivc isolates. J Virol 1992; 66:235-243.
73. Broder CC, Berger EA: CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type I envelope glycoprotein-mediated cell fusion. J Virol 1993:67:913-926.
74. Celada F, Cambiaggi C, Maccari J, Burastero S, Gregory T, Patzer E, Porter J, McDanal C, Matthews T: Antibody raised against soluble CD4-rgp 120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gpl20 binding. J Exp Med 1990; 172 1143-1150.
75. Szabo G, Pine PS. Weaver JL, Rao PE, Aszalos A: CD4 changes conformation upon ligand binding. J Immunol 1992;149:3596-3604.
76. Walker L, Wilks D, Obrien J, Habeshaw J, Dalgleish A: Localized conformational changes in the N-terminal domain of CD4 identified in competitive binding assay of monoclonal antibodies and HIV-I envelope glycoprotein. AIDS Res Hum Retroviruses 1992:8:1083-1090.
77. Planelles V, Chen ISY: The biological and molecular basis for cell tropism in HIV; In Cullen BR (ed): Human Retroviruses. New York, Oxford University Press, 1993, pp 17-48.
78. Miedema F, Meyaard L, Root M, Klein MR, Roos MTL., Grocnink M, Fouchier RAM, Van’t Wout AB. Tersmettc M, Schellekens PTA, Schuitcmakcr H: Changing virus-host interactions in the course of HIV-1 infection. Immunol Rev 1994:140:35-72.
79. Goudsmit J: The role of viral diversity in HIV pathogenesis. J Acquir Immune Defic Syndr Hum R 1995; 10:S15-19.
80. Valentin A, Albert J, Fenyö EM, Asjö B: Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates. J Virol 1994:68:6684-6689.
81. Chowdhurv IH. Potash MJ. Volsky DJ: Redefinition of tropism of common macrophage-tropic human immunodeficiency virus type I, AIDS Res Hum Retroviruses 1995:11:1467-1471.
82. Connor RI, Ho DD: Transmission and pathogenesis of human immunodeficiency virus type I, AIDS Res Hum Retroviruses 1994:10:321-323.
83. +T-cell lines vs. primary macrophages. Proc Natl Acad Sei USA 1995,92: 9004-9008.
84. Alkhatib G, Broder CC, Berger EA: Cell type-specific accessory factors determine human immunodeficiency virus typc-1 tropism for T-cell lines vs. primary macrophages. J Virol 1996; 70:6487-6494.
85. Kang C-Y, Hariharan K, Nara PL, Sodroski J, Moore JP: Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120. J Virol 1994:68:5854-5862.
86. Bedinger P, Moriartv A, Donovan NJ. Steimer KS, Lillman DR: Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4. Nature 1988:334: 162-165.
87. Shin J Y, Dunbrack RL. Lee SJ, Strominger JL: Phosphorylation-dependent downmodulation of CD4 requires a specific structure within the cytoplasmic domain of CD4. J Biol Chem 1991;266:10658-10665.
88. Lapham CK, Ouyang J, Chandrasekhar B, Nguyen NY, Dimitrov DS, Golding H: Evidence forcell-surface association between lusin and the CD4-gpI20 complex in human cell lines. Science 1996:274:602-605.
89. Gudermann T, Nürnberg B, Schultz G: Receptors and G proteins as primary components of transmembrane signal transduction. J Mol Med 1995;73:51-63.
90. Rucker J, Samson M, Doranz BJ, Libert F, Berson JF, Broder CC, Vassart G, Doms RW, Par-mentier M: Regions in β-chemokine receptors CCR-5 and CCR-2b that determine HIV-1 cofactor specificity. Cell 1996:87:437-446.
91. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuki R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR: Homozygous defect in HIV-1 corcceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-377.
92. Samson M, Libert F, Doranz BJ. Rucker J, Liesnard C, Farber C-M, Saragosti S, Lapou-meroulie C, Cogniaux J, Forceillc C, Muyl-dermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RI, Collman RG, Dorns RW, Vassart G, Parmen-tier M: Resistance to HIV-I infection of Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature 1996:381:722-725.
93. Klein MR, Miedema F: Long-term survivors ofHIV-l infection. Trends Microbiol 1995:3: 386-391.
94. Gillespie FP, Doros L, Vitale J, Blackwell C, Gosselin J, Snyder BW, Wadsworth SC: Tissue-specific expression of human CD4 in transgenic mice. Mol Cell Biol 1993:13:2952-2958.
95. Killeen N, Sawada S, Littman DR: Regulated expression of human CD4 rescues helper T-cell development in mice lacking expression of endogenous CD4. EMBOJ 1993:12:1547-1553.
96. Hanna Z, Simard C, Laperriere A, Jolicoeur P: Specific expression of the human CD4 gene in mature CD4(+) CD8(-) and immature CD4(+) CD8(+) T cells and in macrophages of transgenic mice. Mol Cell Biol 1994:14:1084-1094.
97. Dunn CS, Mehtali M, Houdebine LM, Gut J-P, Kirn A, Aubertin A-M: Human immunodeficiency virus type I infection of human CD4-transgcnic rabbits. J Gen Virol 1995:76: 1327-1336.
98. Snyder BW, Vitale J, Milos P, Gosselin J, Gillespie F, Ebert K, Hague BF, Kindt TJ, Wadsworth S, Leibowitz P: Developmental and tissue-specific expression of human CD4 in transgenic rabbits. Mol Reprod Dev 1995: 40:419-428.
99. Trono D: Molecular biology of HIV. Clin Lab med 1994;14:203-220.
100. Cho S, Kindt TJ, Zhao T-M. Sawasdikosol S, Hague BF: Replication of HIV type I in rabbit cell lines is not limited by deficiencies in tat. rev. or long terminal repeat function. AIDS Res Hum Retroviruses 1995:11:1487-1493.
101. Capon DJ, Chamow SM, Mordenti J, Mars-ters SA, Gregory T, Mitsuya H, Bvrn RA, Lucas C, Wurm FM, Groopman JE: Designing CD4 immunoadhesins for AIDS thcrapv. Nature 1989:337:525-531.
102. Wild CT, Shugars DC, Grecnwell TK, McDanal CB, Matthews TJ: Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc Natl Acad Sci USA 1994;91:9770-9774.
103. Dimitrov DS: Fusin - a place for HIV-1 and T4 cells to meet. Nature Med 1996:2:640-641.
104. Zhang L, Huang Y, He T, Cao Y, Ho DD: HIV-1 subtypes and second receptor use (scientific correspondence). Nature 1996:383: 768.
105. Simmons G, Wilkinson D, Reeves JD, Ditl-mar MT, Beddows S, Weber J, Carnegie G, Desselberger U, Gray PW, Weiss RA, Clapham PR: Primary', syncytium-inducing human immunodeficiency virus type I isolates arc dual-tropic and most can use either lestror CCR5 as coreceptors for virus entry. J Virol 1996;70:8355-8360.
106. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goederl JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donficld S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study, O’Brien SJ: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996:273:1856-1862.
107. Wu L, Gerard NP. Wyatt R, Choe H, Parolin C, Ruffing N, Borsetti A, Cardoso AA. Des-jardin E, Newman W, Gerard C, Sodroski J: CD4-induccd interaction of primary HIV-1 gp 120 glycoproteins with the chemokine receptor CCR-5. Nature 1996:384:179-183.
108. Trkola A, Dragic T, Arthos J, Binley JM, Olson WC, Allaway GP. Cheng-Mayer C, Robinson J, Maddon PJ, Moore JP: CD4-dependen antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 Nature 1996;384:184-187.